Veradermics, Inc — Form SCHEDULE 13D/A
Filed August 21, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 12/100
What the filing says
This is a Schedule III disclosure (not Schedule 13D/A as mislabeled) listing officers and directors of Averill Master Fund Ltd., Averill Madison Master Fund Ltd., and Montanova Capital LLC. Named individuals include Sherri Fleming and William Shaw (Cayman-based fiduciaries at Maples), Aaron Cowen (Managing Member of Montanova Capital), Kishan Mehta (Portfolio Manager), Glenn Shepard (CFO), and Andrew Nathanson (General Counsel). No ownership percentages, share counts, or dollar amounts tied to Veradermics are disclosed in this excerpt.
Why this rating
Routine disclosure of fund personnel; no material transaction, ownership stake, or business impact identified. Administrative filing.
See more from August 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.